FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2017972191> ?p ?o ?g. }

• W2017972191 endingPage "1628" @default.
• W2017972191 startingPage "1627" @default.
• W2017972191 abstract "The demonstration of statistical associations between states or events naturally suggests that the congruity may be more than coincidental. Possibilities include that the two (or more) states have an underlying common cause, or that one event or state is affecting or causing the other. Nonskeptical acceptance of the latter post hoc, ergo propter hoc theorem may result in erroneous conclusions. A notable example occurred early in the last century with the statistical demonstration that individuals who contracted tuberculosis appeared to have a lower subsequent incidence of bronchogenic carcinoma. A well-known statistician of that era suggested that the tuberculous infection somehow conferred some protection from neoplastic change. An equally logical explanation, which initially eluded the thinkers of that era, was that the tuberculous disease, for which there was little effective therapy, carried with it a high mortality that prevented many younger consumptives from reaching the age levels in which pulmonary neoplasms have a significant incidence. After the statistical association between smoking and bronchogenic carcinoma was clearly demonstrated in the 1950s and 1960s, the howls of denial from the tobacco industry were echoed faintly by disinterested, honest statisticians exploring the possibilities that the association might not be cause and effect. One such postulate, the Fisher hypothesis, suggested a genetic predisposition toward smoking that might also entail a predisposition toward developing bronchogenic carcinoma. Critics pointed out that these studies were showing associations of smoking not only with lung cancer and emphysema, but also with cancers in other organs (such as the urinary bladder), and even with the incidence of industrial accidents. It was postulated that the results were almost “too good,” suggesting the presence of some type of systematic statistical error, which might even call into question the validity of the most robust association, that of smoking and primary lung cancer. We now realize that many inhaled carcinogens can be absorbed readily through bronchial and alveolar walls and, thus, easily gain access to extrapulmonary organs through the systemic circulation. Although the rationale for increased industrial accidents in smokers is not so clear-cut, it is not too difficult to postulate a few possible explanations for the association. The study by Murin and Inciardi in this issue of CHEST (see page 1635) indicates an association between tobacco smoking and an increased incidence of pulmonary metastases from primary breast carcinoma. Although the association appears to be real, it needs to be confirmed by further studies. A possible association of tobacco smoking with the development of pulmonary metastases from other organs, such as the kidney, also should be investigated. It seems logical that the association may represent a cause-and-effect relationship between inhaled tobacco smoke and the development of pulmonary metastases. The mechanism, though, is not clearly definable. One may postulate that inhaled carcinogens from tobacco smoke are absorbed into the pulmonary circulation and then carried to the site of the primary breast tumor to stimulate the release of tumor material into the systemic veins or lymphatics. Conversely, The effect of the circulating carcinogens from tobacco smoke may stimulate the growth of occult metastases in the lungs. A third possibility is that the inhaled carcinogens somehow affect or alter the pulmonary tissues to make them more receptive to tumor embolization or lymphangitic spread. This study, if confirmed by others, points to the desirability of providing effective treatment for tobacco dependence for those women who are still smoking at the time of breast carcinoma diagnosis. Proven agents, such as bupropion sustained release (Zyban; Glaxo Wellcome; Research Triangle Park, NC) and the nicotine patch are often successful.1Lillington GA Leonard CT Sachs DPL Smoking cessation: techniques and benefits.Clin Chest Med. 2000; 21: 199-208Abstract Full Text Full Text PDF PubMed Scopus (18) Google Scholar2Dale LC Ebbert JO Hays JT et al.Treatment of nicotine dependence.Mayo Clin Proc. 2000; 75: 1311-1316Abstract Full Text Full Text PDF PubMed Scopus (33) Google Scholar In some instances, higher doses of nicotine may be required, using multiple nicotine patches and/or nicotine nasal sprays or inhalers.2Dale LC Ebbert JO Hays JT et al.Treatment of nicotine dependence.Mayo Clin Proc. 2000; 75: 1311-1316Abstract Full Text Full Text PDF PubMed Scopus (33) Google Scholar3Sachs DPL Benowitz NL Bostrom AG et al.Percent serum replacement and success of nicotine patch therapy [abstract].Am J Respir Crit Care Med. 1995; 151: A688Crossref PubMed Google Scholar4Benowitz NL Zevin S Jacob III, P Suppression of nicotine intake during ad libitum cigarette smoking by high-dose transdermal nicotine.J Pharmacol Exp Ther. 1998; 287: 958-962PubMed Google Scholar Such regimens, with individualized doses and accurate monitoring, are safe and effective.2Dale LC Ebbert JO Hays JT et al.Treatment of nicotine dependence.Mayo Clin Proc. 2000; 75: 1311-1316Abstract Full Text Full Text PDF PubMed Scopus (33) Google Scholar5Zevin S Jacob III, P Benowitz NL Dose-related cardiovascular and endocrine effects of transdermal nicotine.Clin Pharmacol Ther. 1998; 64: 87-95Crossref PubMed Scopus (80) Google Scholar6Benowitz NL Nicotine safety and toxicity. Oxford University Press, New York, NY1998Google Scholar Additionally, women who have stopped tobacco smoke exposure only within the previous 12 months should be closely monitored for tobacco use, since relapse back to tobacco use is greatest within the first 12 months after stopping smoking. Vigorous treatment for achieving smoking cessation will probably become part of standard therapy in smokers with breast carcinomas." @default.
• W2017972191 created "2016-06-24" @default.
• W2017972191 creator A5009945232 @default.
• W2017972191 creator A5025294719 @default.
• W2017972191 date "2001-06-01" @default.
• W2017972191 modified "2023-09-26" @default.
• W2017972191 title "Cigarette Smoking, Pulmonary Metastases, and Breast Carcinoma" @default.
• W2017972191 cites W1869016054 @default.
• W2017972191 cites W2049458358 @default.
• W2017972191 cites W2055774348 @default.
• W2017972191 cites W628732671 @default.
• W2017972191 cites W93621506 @default.
• W2017972191 doi "https://doi.org/10.1378/chest.119.6.1627" @default.
• W2017972191 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11399679" @default.
• W2017972191 hasPublicationYear "2001" @default.
• W2017972191 type Work @default.
• W2017972191 sameAs 2017972191 @default.
• W2017972191 citedByCount "5" @default.
• W2017972191 crossrefType "journal-article" @default.
• W2017972191 hasAuthorship W2017972191A5009945232 @default.
• W2017972191 hasAuthorship W2017972191A5025294719 @default.
• W2017972191 hasBestOaLocation W20179721911 @default.
• W2017972191 hasConcept C11171543 @default.
• W2017972191 hasConcept C120665830 @default.
• W2017972191 hasConcept C121332964 @default.
• W2017972191 hasConcept C121608353 @default.
• W2017972191 hasConcept C126322002 @default.
• W2017972191 hasConcept C142724271 @default.
• W2017972191 hasConcept C144024400 @default.
• W2017972191 hasConcept C149923435 @default.
• W2017972191 hasConcept C15744967 @default.
• W2017972191 hasConcept C2776256026 @default.
• W2017972191 hasConcept C2777546739 @default.
• W2017972191 hasConcept C2779134260 @default.
• W2017972191 hasConcept C2780900520 @default.
• W2017972191 hasConcept C2781069245 @default.
• W2017972191 hasConcept C3017622291 @default.
• W2017972191 hasConcept C61511704 @default.
• W2017972191 hasConcept C67636389 @default.
• W2017972191 hasConcept C71924100 @default.
• W2017972191 hasConceptScore W2017972191C11171543 @default.
• W2017972191 hasConceptScore W2017972191C120665830 @default.
• W2017972191 hasConceptScore W2017972191C121332964 @default.
• W2017972191 hasConceptScore W2017972191C121608353 @default.
• W2017972191 hasConceptScore W2017972191C126322002 @default.
• W2017972191 hasConceptScore W2017972191C142724271 @default.
• W2017972191 hasConceptScore W2017972191C144024400 @default.
• W2017972191 hasConceptScore W2017972191C149923435 @default.
• W2017972191 hasConceptScore W2017972191C15744967 @default.
• W2017972191 hasConceptScore W2017972191C2776256026 @default.
• W2017972191 hasConceptScore W2017972191C2777546739 @default.
• W2017972191 hasConceptScore W2017972191C2779134260 @default.
• W2017972191 hasConceptScore W2017972191C2780900520 @default.
• W2017972191 hasConceptScore W2017972191C2781069245 @default.
• W2017972191 hasConceptScore W2017972191C3017622291 @default.
• W2017972191 hasConceptScore W2017972191C61511704 @default.
• W2017972191 hasConceptScore W2017972191C67636389 @default.
• W2017972191 hasConceptScore W2017972191C71924100 @default.
• W2017972191 hasIssue "6" @default.
• W2017972191 hasLocation W20179721911 @default.
• W2017972191 hasLocation W20179721912 @default.
• W2017972191 hasOpenAccess W2017972191 @default.
• W2017972191 hasPrimaryLocation W20179721911 @default.
• W2017972191 hasRelatedWork W1933979619 @default.
• W2017972191 hasRelatedWork W1987994790 @default.
• W2017972191 hasRelatedWork W2031794888 @default.
• W2017972191 hasRelatedWork W2134639919 @default.
• W2017972191 hasRelatedWork W2351757746 @default.
• W2017972191 hasRelatedWork W2380167350 @default.
• W2017972191 hasRelatedWork W2410699560 @default.
• W2017972191 hasRelatedWork W2979804480 @default.
• W2017972191 hasRelatedWork W3094220513 @default.
• W2017972191 hasRelatedWork W4224222467 @default.
• W2017972191 hasVolume "119" @default.
• W2017972191 isParatext "false" @default.
• W2017972191 isRetracted "false" @default.
• W2017972191 magId "2017972191" @default.
• W2017972191 workType "article" @default.